Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
Completed · Phase 3
Conditions studied: Multiple Myeloma
In brief
The purpose of the study is to compare the progression-free survival (PFS) of once-weekly carfilzomib dosing in combination with dexamethasone to twice-weekly carfilzomib dosing in combination with dexamethasone in adults with relapsed and refractory multiple myeloma, previously treated with bortezomib and an immunomodulatory agent (IMiD).
Key facts
- Study ID
- NCT02412878
- Run by
- Amgen
- People needed
- 478
- Starts
- 2015-09-09
- Expected to finish
- 2019-01-07
- Last updated by the study team
- 2022-09-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Scottsdale, Arizona, United States
- Research Site — Bethesda, Maryland, United States
- Center for Cancer and Blood Disorders — Bethesda, Maryland, United States
- Research Site — Rockville, Maryland, United States
- Maryland Oncology Hematology, P.A — Rockville, Maryland, United States
- Research Site — Hackensack, New Jersey, United States
- John Theurer Cancer Center at Hackensack University Medical Center — Hackensack, New Jersey, United States
- Research Site — New York, New York, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Tyler, Texas, United States
- Blood and Cancer Center of East Texas — Tyler, Texas, United States
- Research Site — Darlinghurst, New South Wales, Australia
- Research Site — Tweed Heads, New South Wales, Australia
- Research Site — Waratah, New South Wales, Australia
- Research Site — Box Hill, Victoria, Australia
- Research Site — Antwerp, Belgium
- Research Site — Bruges, Belgium
- Research Site — Brussels, Belgium
- Research Site — Brussels, Belgium
- Research Site — Ghent, Belgium
- Research Site — Leuven, Belgium
- Research Site — Calgary, Alberta, Canada
- Research Site — Kelowna, British Columbia, Canada
- Research Site — Vancouver, British Columbia, Canada
- Research Site — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.